Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-04-24

FDA Approved: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE — Original Application (Solco Healthcare US, LLC)

View source ↗

Summary

FDA approved the original abbreviated new drug application for a generic olmesartan medoxomil and hydrochlorothiazide combination tablet for hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Olmesartan Medoxomil and Hydrochlorothiazide (olmesartan medoxomil; hydrochlorothiazide)

Snippet

ORIG AP for OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE (OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE)